What were the main drivers of EIDP's sales growth in 2022?

EIDP's sales growth in 2022 was primarily driven by a 10% increase in price, reflecting strong execution of its 'price for value' strategy in response to cost inflation and recovery of higher input costs, coupled with a 5% increase in volume due to continued penetration of new products and gains in all regions.

How did Corteva manage rising input costs?

Corteva managed rising input costs through a combination of pricing actions, ongoing cost and productivity improvements, and by offsetting some of the impact through currency benefits. The company also utilizes hedging strategies for certain raw material purchases.

What is EIDP's outlook for 2023?

EIDP has a positive outlook for 2023, anticipating robust demand for its products. The company expects net sales to be in the range of $18.1 billion to $18.4 billion and Operating EBITDA to be between $3.4 billion and $3.6 billion.

What are Corteva's key strategic priorities moving forward?

Corteva's key priorities include accelerating performance and growth through portfolio simplification and differentiation, increasing investment in its innovation pipeline for sustainable solutions, and disciplined capital deployment in growth and complementary M&A opportunities.

CTA-PB/CTA-PA 10-K FY2022 Annual Report — Revenue, Net Income, EPS

Summary

EIDP, Inc. (Corteva Agriscience) reported strong performance for the fiscal year ended December 30, 2022. The company's net sales increased by 11% year-over-year, driven by robust price execution and a 5% volume increase, despite a 3% unfavorable currency impact. Operating EBITDA saw a significant improvement of 25%, reaching $3.224 billion, attributed to strong pricing, volume gains across all regions, and productivity actions, which more than offset inflationary pressures and currency headwinds. The company continues to prioritize investments in its innovation pipeline, focusing on differentiated and sustainable solutions. Strategic acquisitions, such as Stoller and Symborg, are planned for the first half of 2023 to bolster the biologicals portfolio. EIDP also returned significant capital to shareholders through share repurchases and dividends, underscoring its commitment to shareholder value. While facing challenges such as input cost volatility and geopolitical uncertainties, the company's outlook for 2023 remains positive, with projected net sales between $18.1 billion and $18.4 billion.

Key Highlights

1Net sales increased by 11% to $17.455 billion in 2022, driven by a 10% price increase and 5% volume growth.

2Operating EBITDA grew by 25% to $3.224 billion in 2022, reflecting strong price execution and productivity gains.

3The company returned approximately $1.4 billion to shareholders in 2022 through share repurchases and dividends.

4Corteva announced definitive agreements to acquire Stoller and Symborg for an aggregate purchase price of $1.6 billion to supplement its crop protection business with biological tools.

5Restructuring actions, including a Russia exit, are expected to yield $210-$220 million in run-rate savings by 2025.

6The company's Seed segment net sales increased by 7% to $8.979 billion, and Crop Protection segment net sales increased by 17% to $8.476 billion in 2022.

7The company remains committed to innovation, with a focus on R&D investment to deliver value to growers and advance global food security.

EIDP, Inc. Annual Report, Year Ended Dec 31, 2022

Summary

Key Highlights

Frequently Asked Questions